Baystreet Staff -

Investor Network Invites You to the Tenax Therapeutics Fiscal Year 2016 Business Review and Update Conference Call and Webcast on Tuesday, March 21, 2017


MORRISVILLE, NC / ACCESSWIRE / March 20, 2017 / Tenax Therapeutics, Inc. (NASDAQ: TENX) will host a conference call and webcast to discuss the results of the fiscal year 2016, to be held Tuesday, March 21, 2017 at 8:30 AM Eastern Time.

Live Event Information

To participate, connect approximately 5 to 10 minutes before the beginning of the event.

A webcast replay will be available for three months, beginning approximately 2 hours after the completion of the live event.

About Tenax Therapeutics

Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The Company owns the North American rights to develop and commercialize levosimendan, a novel, first in class calcium sensitizer/K-ATP activator. For more information, visit

SOURCE: Investor Network